Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rottapharm Biotech OA gene therapy platform
- Development stage
- Preclinical
- Lead developer
- Rotta Research
- Modality
- Gene Therapies
- Administration
- Intraarticular
01
Overview
Rottapharm Biotech is developing a proprietary gene therapy platform for the treatment of osteoarthritis (OA). This platform utilizes adeno-associated virus (AAV) vectors for intra-articular delivery to restore the physiological expression of proteins that are dysregulated in osteoarthritic joint tissue. By targeting specific OA phenotypes and optimizing transgene sequences, the therapy aims to provide long-term, site-specific therapeutic effects directly within the diseased joint while minimizing systemic exposure. The program is currently in preclinical development and focuses on increasing the natural tropism of AAV towards joint tissues and optimizing transgene sequences to improve clinical translation.
- Other names
- Genetic platform for OAAAV-based intra-articular gene therapy for OA
Beyond the preview
Go deeper on Rottapharm Biotech OA gene therapy platform.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rottapharm Biotech OA gene therapy platform.